Armistice Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.3M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $20.4M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $30.7M | Buy |
|
|||||
|
2023
Q2 | $25.6M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $42.7M | Sell |
|
|||||
|
2022
Q2 | $89K | Sell |
|
|||||
|
2022
Q1 | $102M | Sell |
|
|||||
|
2021
Q4 | $145M | Sell |
|
|||||
|
2021
Q3 | $139M | Buy |
|
|||||
|
2021
Q2 | $112M | Buy |
|
|||||
|
2021
Q1 | $94.7M | Buy |
|
|||||
|
2020
Q4 | $64.3M | Buy |
|
|||||
|
2020
Q3 | $60.3M | Hold |
|
|||||
|
2020
Q2 | $58.8M | Buy |
|
|||||
|
2020
Q1 | $36.1M | Buy |
|
|||||
|
2019
Q4 | $32.1M | Buy |
|